Dr. Hashem B. El-Serag, MD MPH

Claim this profile
Studies Non-alcoholic Fatty Liver Disease
Studies Mesenteric Artery Stenosis
1 reported clinical trial
1 drug studied

Clinical Trials Hashem B. El-Serag, MD MPH is currently running

Image of trial facility.

Clinical Care Pathway

for Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFLD. Therefore, the burden of NAFLD and its complications among Veterans is substantial. However, most VA patients with NAFLD are undiagnosed and untreated, and their care is not consistent with practice guidelines. The NAFLD Clinical Care Pathway (NCCP) intervention seeks to close this major gap in the care of Veterans by automatically identifying patients at risk of NAFLD, calculating their risk scores of having severe NAFLD, and educating the primary care providers on the diagnosis and treatment of NAFLD. This clinical trial will test the benefit of this NCCP intervention against usual care in increasing the rates of NAFLD diagnosis as well as referral to and enrollment in appropriate treatment. The study will also identify barriers and promotors of future NCCP implementation.
Recruiting1 award N/A

More about Hashem B. El-Serag, MD MPH

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Hashem B. El-Serag, MD MPH has experience with
  • NAFLD Clinical Care Pathway
Breakdown of trials Hashem B. El-Serag, MD MPH has run
Non-alcoholic Fatty Liver Disease
Mesenteric Artery Stenosis

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hashem B. El-Serag, MD MPH specialize in?
Hashem B. El-Serag, MD MPH focuses on Non-alcoholic Fatty Liver Disease and Mesenteric Artery Stenosis. In particular, much of their work with Non-alcoholic Fatty Liver Disease has involved treating patients, or patients who are undergoing treatment.
Is Hashem B. El-Serag, MD MPH currently recruiting for clinical trials?
Yes, Hashem B. El-Serag, MD MPH is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Hashem B. El-Serag, MD MPH has studied deeply?
Yes, Hashem B. El-Serag, MD MPH has studied treatments such as NAFLD Clinical Care Pathway.
What is the best way to schedule an appointment with Hashem B. El-Serag, MD MPH?
Apply for one of the trials that Hashem B. El-Serag, MD MPH is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top